BG62431B1 - Метод за предотвратяване или инхибиране на оплождането - Google Patents

Метод за предотвратяване или инхибиране на оплождането Download PDF

Info

Publication number
BG62431B1
BG62431B1 BG99867A BG9986795A BG62431B1 BG 62431 B1 BG62431 B1 BG 62431B1 BG 99867 A BG99867 A BG 99867A BG 9986795 A BG9986795 A BG 9986795A BG 62431 B1 BG62431 B1 BG 62431B1
Authority
BG
Bulgaria
Prior art keywords
antiprogestin
amount
ovulation
fertilization
administration
Prior art date
Application number
BG99867A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99867A (bg
Inventor
Gary D. Hodgen
Original Assignee
The Medical College Of Hampton Roads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Medical College Of Hampton Roads filed Critical The Medical College Of Hampton Roads
Publication of BG99867A publication Critical patent/BG99867A/bg
Publication of BG62431B1 publication Critical patent/BG62431B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Catching Or Destruction (AREA)
  • Pens And Brushes (AREA)
  • Fertilizers (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
BG99867A 1993-02-19 1995-08-15 Метод за предотвратяване или инхибиране на оплождането BG62431B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/019,791 US5516769A (en) 1993-02-19 1993-02-19 Method of inhibiting fertilization
PCT/US1994/001804 WO1994018982A1 (en) 1993-02-19 1994-02-18 Method of preventing or inhibiting fertilization

Publications (2)

Publication Number Publication Date
BG99867A BG99867A (bg) 1996-04-30
BG62431B1 true BG62431B1 (bg) 1999-11-30

Family

ID=21795040

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99867A BG62431B1 (bg) 1993-02-19 1995-08-15 Метод за предотвратяване или инхибиране на оплождането

Country Status (24)

Country Link
US (1) US5516769A (ru)
EP (2) EP1159965B1 (ru)
JP (1) JP3054780B2 (ru)
KR (1) KR100232833B1 (ru)
AT (2) ATE286734T1 (ru)
AU (1) AU692150B2 (ru)
BG (1) BG62431B1 (ru)
BR (1) BR9406666A (ru)
CA (1) CA2156493C (ru)
CZ (1) CZ294325B6 (ru)
DE (2) DE69434239T2 (ru)
DK (2) DK1159965T3 (ru)
ES (1) ES2231356T3 (ru)
FI (1) FI114687B (ru)
HU (1) HU221162B1 (ru)
NO (1) NO307916B1 (ru)
NZ (1) NZ262998A (ru)
PL (1) PL175440B1 (ru)
PT (2) PT684825E (ru)
RO (1) RO118565B1 (ru)
RU (1) RU2139055C1 (ru)
SK (1) SK282068B6 (ru)
UA (1) UA41351C2 (ru)
WO (1) WO1994018982A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
CO5190694A1 (es) 1999-08-31 2002-08-29 Jenapharm Gmbh And Co Kg Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) * 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4000273A (en) * 1973-11-01 1976-12-28 Richardson-Merrell Inc. Method for the control of fertility
US4416822A (en) * 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives

Also Published As

Publication number Publication date
UA41351C2 (ru) 2001-09-17
CA2156493C (en) 2002-10-29
BR9406666A (pt) 1996-01-23
NO953242D0 (no) 1995-08-17
CA2156493A1 (en) 1994-09-01
DE69434239D1 (de) 2005-02-17
DE69434239T2 (de) 2006-03-30
DE69430732D1 (de) 2002-07-11
PT1159965E (pt) 2005-03-31
NZ262998A (en) 1997-06-24
CZ205095A3 (en) 1996-01-17
BG99867A (bg) 1996-04-30
EP1159965A3 (en) 2002-05-22
KR960700726A (ko) 1996-02-24
HUT72079A (en) 1996-03-28
PL175440B1 (pl) 1998-12-31
DE69430732T2 (de) 2002-10-24
AU6299294A (en) 1994-09-14
RU2139055C1 (ru) 1999-10-10
SK282068B6 (sk) 2001-10-08
FI114687B (fi) 2004-12-15
HU221162B1 (en) 2002-08-28
ES2231356T3 (es) 2005-05-16
DK1159965T3 (da) 2005-05-23
CZ294325B6 (cs) 2004-11-10
PT684825E (pt) 2002-10-31
NO953242L (no) 1995-08-17
EP1159965B1 (en) 2005-01-12
FI953878A (fi) 1995-08-17
KR100232833B1 (ko) 1999-12-01
SK101395A3 (en) 1997-04-09
FI953878A0 (fi) 1995-08-17
JPH08510992A (ja) 1996-11-19
ATE286734T1 (de) 2005-01-15
EP0684825B1 (en) 2002-06-05
RO118565B1 (ro) 2003-07-30
JP3054780B2 (ja) 2000-06-19
EP1159965A2 (en) 2001-12-05
ATE218347T1 (de) 2002-06-15
EP0684825A4 (en) 1998-01-14
NO307916B1 (no) 2000-06-19
DK0684825T3 (da) 2002-07-15
EP0684825A1 (en) 1995-12-06
AU692150B2 (en) 1998-06-04
WO1994018982A1 (en) 1994-09-01
PL310357A1 (en) 1995-12-11
US5516769A (en) 1996-05-14

Similar Documents

Publication Publication Date Title
DE3855606T2 (de) Verwendung von Melatonin zur Herstellung einer kontrazeptiven Zusammensetzung
JPH1129481A (ja) 月経の出血を少なくし維持された効力を持つ超低投与量避妊薬
JP3937240B2 (ja) 黄体ホルモン関連の破綻出血の最小化
CZ195397A3 (en) Progesteron antagonistically and antiestrogenic active compounds for common use for woman contraception
Saunders Effects of sex steroids and related compounds on pregnancy and on development of the young.
CA2203541A1 (en) Competitive progesterone antagonists for demand-oriented female birth control
US20030018018A1 (en) Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea
BG62431B1 (bg) Метод за предотвратяване или инхибиране на оплождането
KR20020038745A (ko) 여성 피임제 성분으로서의 메조프로게스틴 (프로게스테론수용체 조절물질)
Psychoyos et al. Hormonal anti-implantation agents: antiprogestins
Kaplan-Kraicer et al. Anordiol and RU486 synergize to produce preimplantation pregnancy loss by increasing embryo transport (rat)
Kovacs Luteal contraception
Prasad Post-coital agents and menses inducing drugs
Sen et al. Long-term effect of a continuous daily microdose of norgestrel on the genital organs and fertility of female rats
IL94411A (en) Compositions comprising an analog of melatonin in combination with progestogen and/or estrogen for effecting contraception